<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Main Page</title>
    <link rel="stylesheet" href="style_result.css">
    
</head>
<body>
  <div class="custom-navbar">
    <div class="left-list"> <button class="btn btn-primary" type="button" data-bs-toggle="offcanvas" data-bs-target="#offcanvasWithBothOptions" aria-controls="offcanvasWithBothOptions"><img src="icon.svg" alt=""></button>
        <div class="offcanvas offcanvas-start" data-bs-scroll="true" tabindex="-1" id="offcanvasWithBothOptions" aria-labelledby="offcanvasWithBothOptionsLabel">
          <div class="offcanvas-header">
            <h5 class="offcanvas-title" id="offcanvasWithBothOptionsLabel">Welcome to Anti-Doping</h5>
            <button type="button" class="btn-close" data-bs-dismiss="offcanvas" aria-label="Close"></button>
          </div>
          <div class="offcanvas-body">
            <p>Ensuring a dopefree environment for athletes and sports</p>

            <div class="btn awarenessbtn" style="background-color: white; border: none;">
                <button class="awarenessbtn2" style="border: none; background-color: white; padding: 0;"><a href="index_result.html" class="awarenessanchor" style="color: black; text-decoration: none; background-color: white; border: none;">Result Management</a></button>
              </div><br>
              <div class="btn awarenessbtn" style="background-color: white; border: none;">
                <button class="awarenessbtn2" style="border: none; background-color: white; padding: 0;"><a href="index_resources.html" class="awarenessanchor" style="color: black; text-decoration: none; background-color: white; border: none;">Resources</a></button>
              </div><br>
              <div class="btn awarenessbtn" style="background-color: white; border: none;">
                <button class="awarenessbtn2" style="border: none; background-color: white; padding: 0;"><a href="index_testing.html" class="awarenessanchor" style="color: black; text-decoration: none; background-color: white; border: none;">Athlete Testing</a></button>
              </div><br>
            
              <div class="btn awarenessbtn" style="background-color: white; border: none;">
                <button class="awarenessbtn2" style="border: none; background-color: white; padding: 0;"><a href="index-tue.html" class="awarenessanchor" style="color: black; text-decoration: none; background-color: white; border: none;">Therapeutic Use Exemption</a></button>
              </div>
              <div class="btn awarenessbtn" style="background-color: white; border: none;">
                <button class="awarenessbtn2" style="border: none; background-color: white; padding: 0;"><a href="https://docs.google.com/forms/d/1IpUZLCEWSLM-SlGfUqPGC4GBnnVWrfMVqBVOrTHXGHk/edit" class="awarenessanchor" style="color: black; text-decoration: none; background-color: white; border: none;">Report And Feedback</a></button>
              </div>
          </div>
        </div>DopingDefiance <a href="https://nadaindia.yas.gov.in/" style="margin-left: 30px;">
            <img width="180" height="45" src="https://nadaindia.yas.gov.in/wp-content/uploads/GOV-NADA-Logo-01-1-1024x305.png" class="attachment-large size-large wp-image-6456" alt="" srcset="https://nadaindia.yas.gov.in/wp-content/uploads/GOV-NADA-Logo-01-1-1024x305.png 1024w, https://nadaindia.yas.gov.in/wp-content/uploads/GOV-NADA-Logo-01-1-300x89.png 300w, https://nadaindia.yas.gov.in/wp-content/uploads/GOV-NADA-Logo-01-1-768x229.png 768w, https://nadaindia.yas.gov.in/wp-content/uploads/GOV-NADA-Logo-01-1-1536x458.png 1536w, https://nadaindia.yas.gov.in/wp-content/uploads/GOV-NADA-Logo-01-1.png 1730w" sizes="(max-width: 800px) 100vw, 800px"></a></div>
            <div class="right-list">
                <div class="item-1"><a style="color: black; text-decoration: none;" href="index.html">HOME</a></div>
                <div class="item-3"><a style="color: black; text-decoration: none;" href="index_edu.html">EDUCATION</a></div>
                <div class="item-4"><a style="color: black; text-decoration: none;" href="index_blog.html">BLOG</a></div>
                <div class="item-5"><a style="color: black; text-decoration: none;" href="index_news.html">NEWS</a></div>
            </div>
</div>  
     <div class="img1">
      <img src="disabled-female-athlete-competing-official-paralympic-games-3.jpg" alt="">
      <div class="text">#FairPlay</div>
    </div>


    <div class="container5 my-3" style="max-width: 1600px; margin: 0 auto;">
      <div class="position-relative p-4 text-center text-muted bg-light border border-dashed rounded-5 shadow-sm" style="background-color: #f8f9fa; border-color: #ddd;">
        <h1 class="text-body-emphasis" style="font-size: 3rem; font-weight: 600; color: #343a40; margin: 0 0 20px 0;">
          Result Management Process
        </h1>
        <p class="col-lg-6 mx-auto mb-3" style="font-size: 1.4rem; color: #6c757d; line-height: 1.6;font-weight: 400; text-align: left;">
          NADA India manages results of Anti-Doping Rule Violations (ADRVs) committed by athletes, athlete support personnel and other persons that fall under its jurisdiction. <br><br>
          Athlete, ASP and other person may receive sanctions for committing anti-doping rule violations. They can either accept the sanctions or challenge before the ADDP and may file appeal before the ADAP.
        </p>
      </div>
    </div>    
    


    <section class="international-reach">
      <h1 style="font-size: 2.5rem; font-weight: 700; margin-bottom: 30px;"> Analysis</h1>
      <div class="reach-grid">
        <div class="reach-card" style="background-image: url('female-athlete-competing-paralympic-games.jpg');">
          <div class="overlay">
            <p class="initial-text">Sample Analysis</p>
            <p class="hover-text">After a Sample is provided by an Athlete, the Doping Control Officer (DCO) will send the Samples to a World Anti-Doping Agency (WADA) accredited laboratory, maintaining a secure chain of custody. On arrival at the laboratory, the “A” sample is analysed first and “B” sample is kept frozen. There are three possible outcomes following sample analysis; <br><br>
              <ul  class="hover-text" style="color: white; text-align: left;">
                <li><b>Negative Result</b></li>
                <li><b>Atypical Finding</b></li>
                <li><b>Adverse Analytical Finding</b></li>
              </ul>
            </p>
          </div>
        </div>
        <div class="reach-card" style="background-image: url('pexels-case-originals-3687021.jpg');">
          <div class="overlay">
            <p class="initial-text">Negative Result</p>
            <p class="hover-text">In the absence of a prohibited substance (and/or its metabolites and markers) and evidence of prohibited methods, the laboratory issues a negative test result.</p>
          </div>
        </div>
        <div class="reach-card" style="background-image: url('disabled-female-athlete-competing-official-paralympic-games-2[1].jpg');">
          <div class="overlay">
            <p class="initial-text">Atypical Finding</p>
            <p class="hover-text">The presence of a prohibited substance in the A sample may, in some circumstances, constitute an atypical finding. This, will be followed by a review, where NADA will determine whether:
              <br><br>
              <b>A Therapeutic Use Exemption (TUE) was granted</b>
              <br><br>
              <b>A departure from the International Standard for Testing and Investigations or International Standard for Laboratories may have caused the atypical finding</b>
              <br><br>
              <b>The finding was caused by ingestion of a prohibited substance by a permitted route</b>
              <br><br>
              If the review does not reveal any of these to be true, further action is taken according to the International Standard for Results Management. After ISRM, any follow up testing if required.</p>
          </div>
        </div>
        <div class="reach-card" style="background-image: url('disabled-female-athlete-competing-official-paralympic-games[1].jpg');">
          <div class="overlay">
            <p class="initial-text">Adverse Analytical Finding</p>
            <p class="hover-text">Upon receipt of an A Sample Adverse Analytical Finding, NADA determines whether:</p>
              <ul class="hover-text">
                <li>A TUE was granted</li>
                <li>There was a departure from the International Standard for Testing and Investigations or International Standard for Laboratories that may have caused the finding</li>
                  <li>It is apparent that the finding was caused by ingestion of a prohibited substance by a permitted route.</li>
              </ul>
              <p class="hover-text">If the review does not reveal any of the above, then the athlete, the national federation, international federation and WADA are notified of the adverse analytical finding. The athlete can request an analysis of the B sample, within seven days of receiving the notification. If the B sample is negative the entire result is deemed negative and all parties are informed.</p>
            
          </div>
        </div>
      </div>
    </section>


    <div class="img1">
      <img src="img99.jpg" alt="" style="height:236px ; width: 100%;">
    </div>


    
    <div class="containers">
      <h1>Anti Doping Rule Violation (ADRVs)</h1>
      <p>
        As defined in the World Anti-Doping Code 2021, there are 11 Anti-Doping Rules Violations. 
        All of them apply to athletes.
      </p>
      <p>
        Violations 5-11 also apply to Athlete Support Personnel and Other Persons.
      </p>
  
      <div class="violations">
        <ol>
          <li>Presence of a Prohibited Substance or its Metabolites or Markers in an Athlete’s Sample</li>
          <li>Use or Attempted Use by an Athlete of a Prohibited Substance or a Prohibited Method</li>
          <li>Evading, Refusing or Failing to Submit to Sample Collection by an Athlete</li>
          <li>Whereabouts Failures by an Athlete</li>
          <li>Tampering or Attempted Tampering with any Part of Doping Control by an Athlete or Other Person</li>
          <li>Possession of a Prohibited Substance or a Prohibited Method by an Athlete or Athlete Support Personnel </li>
          <li>Trafficking or Attempted Trafficking in any Prohibited Substance or Prohibited Method by an Athlete or Other Person</li>
          <li>Administration or Attempted Administration by an Athlete or Other Person to any Athlete In-Competition of any Prohibited Substance or Prohibited Method, or Administration or Attempted Administration to any Athlete Out-of-Competition of any Prohibited Substance or any Prohibited Method that is Prohibited Out-of-Competition</li>
          <li>Complicity or Attempted Complicity by an Athlete or Other Person</li>
          <li>Prohibited Association by an Athlete or Other Person</li>
          <li>Acts by an Athlete or Other Person to Discourage or Retaliate Against Reporting to Authorities </li>
        </ol>
      </div>
  
      <div class="downloads">
        <a href="https://nadaindia.yas.gov.in/wp-content/uploads/Revised-ADRV-July-2023-Leaflet.jpg" class="button">ADRV INFORMATION</a>
        <button class="button"onclick="window.location.href='result_1.pdf';">List of Provisionally Suspended Athletes</button>
      </div>
    </div>


      <div class="main-container">
        <div class="top-section">
          <h1>Reduction Of Sanction</h1>
          <h5>A sanction may be reduced in a number of ways, depending on the nature of the ADRV, the timing of any admission to the charge and/or the nature of the Prohibited Substance(s) detected in an Athlete’s sample. Reductions can be applied due to:</h5>
        </div>
        <div class="bottom-section">
          <div class="left-box">
            <ol>
              <li><p>Voluntarily admitting the ADRV in the absence of other evidence.</p></li>
              <li><p>Reaching a case resolution agreement with NADA India and WADA and applying a reduction after assessing the individual’s degree of Fault, the seriousness of the ADRV, and how promptly the violation was admitted.</p></li>
              <li><p>An Athlete establishing that their use of a non-Specified Substance was not ‘intentional’ (as that term is defined in the rules). This will also usually require the Athlete to establish how the Prohibited Substance entered their system.</p></li>
              <li><p>Establishing ‘No Fault or Negligence’, or alternatively ‘No Significant Fault or Negligence’. A ban may be eliminated entirely as a result of No Fault or Negligence when an individual can establish that they did not know or suspect, or could not have reasonably known or suspected, even with the utmost caution, that they had violated an anti-doping rule. No Fault or Negligence is applied in very rare circumstances.</p></li>
            </ol>
          </div>
          <div class="right-box">
            <ol>
              <li><p>The application of No Significant Fault or Negligence occurs where the individual establishes that any Fault or negligence, when viewed in the totality of the circumstances, was not significant. Reductions for No Significant Fault or Negligence may also be applied in cases involving Specified Substances or Specified Methods, Contaminated Products or Athletes who are classed as ‘Protected Persons’ or ‘Recreational Athletes’.</p></li>
              <li><p>Reaching a Results Management Agreement in a situation where an Athlete is facing a ban of four or more years, if they accept the ADRV(s) and applicable consequences within 20 days from the date of the receipt of Notice of Charge, then he/she will be entitled to a reduction of one year ineligibility period.</p></li>
              <li><p>The ADRV involving a ‘Substance of Abuse’. An Athlete may receive a reduced sanction of three months if the Athlete is comfortable.</p></li>
            </ol>
          </div>
        </div>
      </div>
      
      

      <div class="container my-5" style="max-width: 1600px; margin: auto;">
        <div 
          class="position-relative text-center text-muted bg-body border rounded-5" 
          style="
            background-color: #f8f9fa; 
            border: 2px dashed #6c757d; 
            border-radius: 20px; 
            box-shadow: 0 8px 16px rgba(0, 0, 0, 0.2); 
            padding: 30px; 
            color: #495057;"
        >
          <h1 
            class="text-body-emphasis" 
            style="
              font-size: 2rem; 
              font-weight: 700; 
              color: #212529; 
              margin-bottom: 15px;"
          >
          Sanctions under Result Management Agreement (Article 10.8.1 or 8.3)
          </h1>
          <p 
            class="col-lg-6 mx-auto" 
            style="
              font-size: 1rem; 
              line-height: 1.5; 
              color: #6c757d; 
              max-width: 800px; 
              margin-bottom: 20px;"
          >
Please click on the link below to download the detailed document on Sanctions under Result Management Agreement (Article 10.8.1 or 8.3)          </p>
<a download class="btn btn-success px-4 mb-3" style="font-size: 1rem; padding: 10px 20px; background-color: #1f2521c3; border:2px solid goldenrod; border-radius: 25px; transition: background-color 0.3s ease;"onclick="window.location.href='result_2.pdf';">
  <svg xmlns="http://www.w3.org/2000/svg" width="20" height="20" fill="currentColor" class="bi bi-file-earmark-arrow-down me-2" viewBox="0 0 16 16">
    <path d="M8 0a2 2 0 0 1 2 2v4.5h1.5a2 2 0 0 1 2 2v4.5a2 2 0 0 1-2 2H8a2 2 0 0 1-2-2V6.5H2a2 2 0 0 1-2-2V2a2 2 0 0 1 2-2h6zm3 10a.5.5 0 0 1-.5-.5V7h-2V6h2V5a.5.5 0 0 1 1 0v1h2v1h-2v2.5a.5.5 0 0 1-.5.5zM3 10a.5.5 0 0 1-.5-.5V6.5a.5.5 0 0 1 .5-.5H4v1H3.5v2H4v1H3.5z"/>
  </svg>
  DOWNLOAD SANCTIONS
</a>
        </div>
      </div>

      <div class="footer">
        <div class="footer-content">
            <div class="img" style="background-color: white; border-radius: 20px; width: 150px; text-align: center;"><img src="th.jpg" alt=""></div>
            <div class="contact-us">
                <h2 class="fifth-h2" style="color: white; margin: auto;">Contact Us</h2>
                <section ><span style="color: white; width: 10px;">Lorem ipsum dolor sit amet consectetur adipisicing elit. In, vero.</span></section>
                <section><span style="color: white;">+91-11-24368274</span></section>
                <section class="mail"><span style="color: white;">info[dot]nada[at]nic[dot]in</span></section>
            </div>
            <div class="links" style="text-align: center;">
                <h2 class="sixth-h2" style="color: white; margin: auto;">Links</h2>
                <ul style="text-align: center;">
                  <li style="color: white; list-style-type: none; "><a href="index.html" style="color: white; text-decoration: none;">HOME</a></li>
                  <li style="color: white; list-style-type: none;"><a href="index_testing.html" style="color: white; text-decoration: none;">Athlete Testing</a></li>
                  <li style="color: white; list-style-type: none;"><a href="https://www.wada-ama.org/en/prohibited-list#search-anchor" style="color: white; text-decoration: none;">Prohibited Substances</a></li>
                  <li style="color: white; list-style-type: none;"><a href="index_edu.html" style="color: white; text-decoration: none;">Education and awareness</a></li>
                  <li style="color: white; list-style-type: none;"><a href="index-tue.html" style="color: white; text-decoration: none;">TUE</a></li>
              </ul>
            </div>
            <div class="follow-us" style="text-align: center;">
                <h2 class="seventh-h2" style="color: white; margin: auto;">Follow Us</h2>
                <ul style="display: flex; margin: 58px 0 0 43px;">
                  <li style="list-style-type: none; padding: 5px; height: 20px;"> <a href="https://www.instagram.com/doping_defiance"> <img src="insta.svg" alt=""> </a></li>
                  <li style="list-style-type: none; padding: 5px; height: 20px;"> <a href="https://x.com/doping_defiance"> <img src="twitter.svg" alt=""> </a> </li>
                  <li style="list-style-type: none; padding: 5px; height: 20px;"> <a href="https://www.threads.net/@doping_defiance"> <img src="tr.svg" alt=""></a></li>
              </ul>
            </div>
        </div>
    </div>
      
      
    <script> window.chtlConfig = { chatbotId: "2624484363" } </script>
    <script async data-id="2624484363" id="chatling-embed-script" type="text/javascript" src="https://chatling.ai/js/embed.js"></script>


</body>
<link href="https://cdn.jsdelivr.net/npm/bootstrap@5.3.3/dist/css/bootstrap.min.css" rel="stylesheet">
<script src="https://cdn.jsdelivr.net/npm/bootstrap@5.3.3/dist/js/bootstrap.bundle.min.js"></script>
</html>